genedrive plc (FRA:D6M)

Market Cap	11.71M
Revenue (ttm)	741.26K
Net Income (ttm)	-8.91M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	14,415
Open	0.0100
Previous Close	0.0145
Day's Range	0.0100 - 0.0100
52-Week Range	0.0005 - 0.0305
Beta	n/a
RSI	51.97
Earnings Date	Nov 28, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides c system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Cl...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 43
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D6M

Financial Performance

In 2024, genedrive's revenue was 501,000, an increase of 810.91% compared to the previous year's 55,000. Losses were -7.08 million, 37.4% more than in 2023.

Financial numbers in GBP